Home | Welcome to Contract Pharma   
Last Updated Wednesday, October 22 2014
Print

Search Results for 'Phase II'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

By Gil Roth
Published October 11, 2013
Trial showed no PML cases Read More »
By Gil Roth
Published October 9, 2013
IPT trials in patients with wet AMD and VMT Read More »
Published February 27, 2012
Following initial safety (Phase I) testing, a drug is tested for efficacy, typically in blind, randomized trials, in which a control group receives a placebo. Phase II testing may last from several months to two years. Phase II trials involve 100-300… Read More »
Published May 25, 2011
Sixth milestone resulting from 2005 CNS pact Read More »
Published April 15, 2011
Galapagos NV will discontinue its Phase II trial for GLPG0259 in rheumatoid arthritis (RA) following a planned interim analysis that did not support continuing development of the drug for RA. Read More »
Published March 21, 2011
Genentech’s Phase II study of its investigational Hedgehog Pathway Inhibitor, vismodegib (RG3616/GDC-0449), showed positive results in people with advanced basal cell carcinoma (aBCC), a severe form of skin cancer. Read More »
Published May 27, 2010
Peregrine Pharmaceuticals achieved positive results from a Phase II trial evaluating bavituximab in combination with paclitaxel and carboplatin chemotherapy in patients with advanced breast cancer. Read More »
Published March 15, 2010
Portola Pharmaceuticals and Merck achieved positive results from EXPLORE-Xa, a Phase II dose finding study of investigational oral direct Factor Xa inhibitor betrixaban. Read More »
By Gil Roth
Published December 12, 2013
Reaches PFS, but OS numbers don't separate against placebo Read More »
By Michael Baker, VP, Ockham Oncology
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On